Foghorn posts investor presentation; no material financial or pipeline updates disclosed

Foghorn Therapeutics Inc.

Company posted a corporate presentation to its website on May 6, 2024, for use in investor meetings.
Presentation attached as Exhibit 99.1 contains cover slide only; no specific financial data, clinical milestones, or guidance provided.
No changes to previously disclosed business strategy or pipeline status were announced.
Filing contains no earnings results, regulatory actions, or material contracts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.